News

Toujeo has been given an added indication which allows its use for blood sugar control in patients as young as 6 years old.

Arjun Masurkar, MD, PhD, previews some of the new medications that could help treat Alzheimer disease, while reviewing some of the advancements of the last decade.

A new study of more than 100,000 patients in the UK found patients living in areas with greater amounts of air pollution were at an increased risk of glaucoma.

The deoxygenated sickle hemoglobin polymerization inhibitor was granted Accelerated Approval designation for the burdensome rare disease.

Novartis AG is set to acquire The Medicines Company in a $9.7 billion deal that is set to be completed in the first quarter of 2020.

In a study based in Finland, investigators link different types of oral antibiotics to an increased risk of Parkinson disease.

Investigators examine how different supplementation impacts kidney function in patients with type 2 diabetes.

Patient demographics influence difference symptoms, progression, and benefits of care.

How to weigh the 5 agents from the drug class, which have each shown differing benefit in younger patients.

New data suggests that bipolar disorder 1 is linked with longer sleep durations, while bipolar disorder II is tied to insomnia.

Though vaccination rates are decreasing in children and adolescents overall, it is not due to consideration of previous season's successes or failures.

Results of the CITU study are revealing more about the different impacts e-cigarette and tobacco use has on a patient's lipid profile.

The once-daily oral therapy is recommended at a 200 mg dose, following titration.

A new analysis from the University of Minnesota has found many patients with and without an indication for regular low dose aspirin use are under or overusing the medication.

The approval allows Medtronic to move forward with the IN.PACT AV balloon to treat failing arteriovenous access for patients with end-stage renal disease undergoing dialysis.

The new approval grants BD the ability to move forward with a new device aimed at repairing abdominal hernias.

The therapy was shown in a 94-patient trial to reduce porphyria attacks by 70% versus placebo.

The FDA gives a green light to MiSight, a single use, contact lens to slow the progression of nearsightedness in children.

Crizanlizumab is the first ever drug approved to reduce vaso-occlusive crises in patients with the rare blood disease.

In the pivotal assessment, three-quarters of patients who received cefiderocol had resolution of symptoms and eradication of the bacteria 1 week after completing treatment, versus 54.6% of patients who received an alternative antibiotic.

The IL-5 inhibitor has shown significant benefits for HES in a phase 3 pivotal trial, and is now being considered for regulatory submission.

Listen in to the audio transcript of a policy- and public health-based discussion on mental health stigma from a panel of experts.

How the greatest use of the drug class may just come in the most severe cases.

The rate of pediatric and adolescent patients adhering to 30-day corticosteroid refill schedules increased by nearly 50 percentage points.

A new survey shows more than 60% of adult patients with peanut allergy do not feel confident in managing their condition, despite taking preventive measures.

The ALK-Abello expert details the positive findings from the vast, novel assessment of Ragwitek in children with ragweed allergic rhinitis with or without conjunctivitis.

New findings show Viaskin Peanut provided significant improvements to HRQL over placebo in a pair of its clinical trials.

The US FDA has approved lusaptercept-aamt (Reblozyl) for the treatment of anemia in adult patients with beta thalassemia who require regular blood red blood cell transfusions.